Affinity and kinetic studies for the evaluation of lectin-reactive α- fetoprotein with a biosensor based on surface plasmon resonance

Hepatology Research

Volumn 8, Issue 2, 1997, Pages 95-105

  Kato, Kimitoshi ^a   Asai, Satoshi ^a   Taga, Hiroko ^a   Tominaga, Yuichi ^b   Ishikawa, Koichi ^a   Arakawa, Yasuyuki ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b DAIICHI SANKYO CO   (Japan)

Author keywords

BIA core; Kinetic analysis; Lectin; Surface plasmon resonance; Fetoprotein (AFP)

Indexed keywords

AGGLUTININ; ALPHA FETOPROTEIN; CONCANAVALIN A; PHYTOHEMAGGLUTININ;

ARTICLE; BIOSENSOR; DIAGNOSTIC PROCEDURE; DISSOCIATION CONSTANT; HUMAN; HUMAN CELL; LECTIN BINDING; LIVER CELL CARCINOMA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN IMMOBILIZATION; PROTEIN PURIFICATION; REACTION ANALYSIS; SURFACE PLASMON RESONANCE;

EID: 0030759161     PISSN: 09284346     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1386-6346(97)00055-7     Document Type: Article

References (23)

1. Alpert E, Hershberg R, Schur PH, Isselbacher KJ. α-Fetoprotein in human hepatoma: improved detection in serum, and quantitative studies using a new sensitive technique. Gastroenterology 1971;61:137-43.
2. Okuda K. Primary liver cancer. Quadrennial review lecture. Dig Dis Sci 1986;31(9):133S-46S.
3. Okuda K, Kotoda K, Obata H, Hayashi N, Hisamatsu T, Tamiya M, Kubo Y, Yakushiji F, Nagata E, Jinnouchi S, Shimokawa Y. Clinical observations during a relatively early stage of hepatocellular carcinoma, with special reference to serum α-fetoprotein levels. Gastroenterology 1975;69:226-34.
4. Nomura F, Ohnishi K, Tanabe Y. Clinical features and prognosis of hepatocellular carcinoma with reference to serum α-feto-protein levels. Cancer 1989;64:1700-7.
5. Oka H, Tamori A, Kuroki T, Kobayashi K, Yamamotc S. Prospective study of α-fetcprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology 1994;19:61-6.
6. Sangalli G, Livraghi T, Giordano F. Fine needle biopsy of hepatocellular carcinoma: improvement in diagnosis by microhistology. Gastroenterology 1989;96:24-6.
7. Takayasu K, Moriyama N, Muramatsu Y, Makuuchi M, Hasegawa H, Okazaki N, Hirohashi S. The diagnosis of small hepatocellular carcinomas: efficacy of various imaging procedures in 100 patients. Am J Roentgenol 1990;155:49-54.
8. Alpert E, Feller ER. α-Fetoprotein (AFP) in benign liver disease: evidence that normal liver regeneration does not induce AFP synthesis. Gastroenterology 1978;74:856-8.
9. Chen DS, Sung JL. Relationship of hepatitis B surface antigen to serum α-fetoprotein in nonmalignant diseases of the liver. Cancer 1979;44:984-92.
10. Lok ASF, Lai C. α-Fetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: role in the early detection of hepatocellular carcinoma. Hepatology 1989;9:110-5.
11. Taketa K, Izumi M, Ichikawa E. Distinct molecular species of human α-fetoprotein due to differential affinities to lectins. Ann NY Acad Sci 1983;417:61-8.
12. Aoyagi Y, Suzuki Y, Isemura M, Soga K, Ozaki T, Ichida T, Inoue K, Sasaki H, Ichida F. Differential reactivity of α-fetoprotein with lectins and evaluation of its usefulness in the diagnosis of hepatocellular carcinoma. Gann 1984;75:809-15.
13. Taketa K, Sekiya C, Namiki M, Akamatsu K, Ohta Y, Enodo Y, Kosaka K. Lectin-reactive profiles of α-fetoprotein characterizing hepatocellular carcinoma and related conditions. Gastroenterology 1990;99:508-18.
14. Narashimhan S, Freed JC, Schachter H. The effect of a 'bisecting' N-acetylglucosaminyl group on the binding of biantennary, complex oligosaccharides to concanavalin A, Phaseolus vulgaris erythroagglutinin (E-PHA), and Recinus communis agglutinin (RCA-120) immobilized on agarose. Carbohydr Res 1989;149:65-83.
15. Aoyagi Y, Suzuki Y, Igarashi K, Saitoh A, Oguro T, Yokota T, Mori S, Suda T, Isemura I, Asakura H. Carbohydrate structures of human α-fetoprotein of patients with hepatocellular carcinoma: presence of fucosylated and non-fucosylated triantennary glycans. Br J Cancer 1993;67:486-92.
16. Fagerstam LG, Frostell-Karlsson A, Karlsson R, Persson B, Ronnberg I. Biospecific interaction analysis using surface plasmon resonance detection applied to kinetic, binding site and concentration analysis. J Chromatogr 1992;597:397-410.
17. Shinohara Y, Kim F, Shimizu M, Goto M, Tosu M, Hasegawa Y. Kinetic measurement of the interaction between an oligosaccharide and lectins by a biosensor based on surface plasmon resonance. Eur J Biochem 1994;223:189-94.
18. Nishi S. Isolation and characterization of a human fetal-αglobulin from the sera of fetuses and a hepatoma patient. Cancer Res 1970;30:2507-13.
19. Nishi S, Hirai H. Purification of human, dog and rabbit α-fetoprotein by immunoadsorbents of sepharose coupled with anti-human α-fetoprotein. Biochim Biophys Acta 1972;278:293-8.
20. O'Shannessy DJ, Brigham-Burke M, Soneson KK, Hensley P, Brooks I. Determination of rate and equilibrium binding constants for macromolecular interactions using surface plasmon resonance: use of nonlinear least squares analysis methods. Anal Biochem 1993;212:457-68.
21. Yoshima H, Mizuochi T, Ishii M, Kobata A. Structure of the asparagine-linked sugar chains of α-fetoprotein purlfied from human ascites fluid. Cancer Res 1980;40:4276-81.
22. Yamashita K, Taketa K, Nishi S, Fukushima K, Ohkura T. Sugar chains of human cord serum α-fetoprotein: characteristics of N-linked sugar chains of glycoproteins produced in human liver and hepatocellular carcinomas. Cancer Res 1993;53:2970-5.
23. Taketa K, Endo Y, Sekiya C, Tanikawa K, Koji T, Taga H, Satomura S, Matsuura S, Kawai T, Hirai H. A collaborative study for the evaluation of lectin-reactive α-fetoproteins in early detection of hepatocellular carcinoma. Cancer Res 1993;53:5419-23.